03 September 2025   The technique of 3D bioprinting of living tissues to recapitulate the structure and function of human organs has shown great promise in disease modelling, drug testing and regenerative medicine. To further enhance the viability, complexity and functional relevance of bioprinted constructs, Riccardo Levato’s team at UMC Utrecht and Utrecht University have developed an innovative modelling methods termed Generative, Adaptive, Context-Aware 3D printing  (GRAC

17 October 2025   Neurodegenerative disorders, such as Alzheimer’s disease  (AD), are highly debilitating, progressive disorders that affect cognitive function and behaviour. Traditionally, biomedical research into AD has relied on animals to model AD pathophysiology and develop treatments. However, none of the treatments tested in AD animal models were able to halt or reverse cognitive decline in AD patients. The failure rate in clinical trials of drugs developed and validat

02 October 2025   Microvessels - capillaries and post‑capillary venules - are the smallest vessels in the circulation, with a cellular composition and thin-walled structure that enables nutrient exchange, oxygen delivery, waste removal, and immune‑cell trafficking between the blood and surrounding tissue cells. The absence of microvascular function is often cited as a major bottleneck of in vitro preclinical models, leading to tissue necrosis and limiting physiological releva

09 December 2025   Riccardo Levato’s team at UMC Utrecht and Utrecht University receives  an ERC Consolidator Grant of approx. €2.3M to advance the next phase of its innovative method of generative, context-aware 3D bioprinting.     The technique of 3D bioprinting of living tissues to recapitulate the structure and function of human organs has shown great promise in disease modelling, drug testing and regenerative medicine. Supported by a 2020 ERC Starting Grant, Riccardo Lev